Log In
BCIQ
Print this Print this
 

BIO-11006 Inhalation Solution

  Manage Alerts
Collapse Summary General Information
Company BioMarck Pharmaceuticals Ltd.
DescriptionMARCKS protein inhibitor
Molecular Target Myristoylated alanine-rich C-kinase substrate (MARCKS)
Mechanism of ActionMyristoylated alanine-rich C-kinase substrate (MARCKS) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD); Treat chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today